| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| A0SB29 | NADH-ubiquinone oxidoreductase chain 5; EC 1.6.5.3; | ND5; | NULL | 603 | human |
| F6U341 | Large proline-rich protein BAG6; Fragment; | BAG6; | NULL | 262 | human |
| D3DWE7 | HCG1994053, isoform CRA_b; | NULL | NULL | 464 | human |
| Q7Y6H2 | NADH-ubiquinone oxidoreductase chain 5; EC 1.6.5.3; | ND5; | NULL | 603 | human |
| F2WEB6 | NADH-ubiquinone oxidoreductase chain 2; EC 1.6.5.3; | ND2; | NULL | 347 | human |
| Q4GF15 | NADH-ubiquinone oxidoreductase chain 5; EC 1.6.5.3; | NADH5; ND5 ndh5; | NULL | 603 | human |
| Q96NE0 | HCG1982013; cDNA FLJ31021 fis, clone HLUNG2000412; | NULL | NULL | 134 | human |
| C8YGU0 | Cytochrome b; | CYTB; | NULL | 380 | human |
| J3KPD3 | RNA binding motif protein 7, isoform CRA_c; RNA-binding protein 7; | RBM7; | NP_001272974.1; | 267 | human |
| D7RII0 | MHC class II antigen; Major histocompatibility complex, class II, DR beta 1; | HLA-DRB1; | NULL | 266 | human |
| D5K9W5 | POU domain protein; | POU5F1P4; | NULL | 286 | human |
| Q4EXD6 | Cytochrome b; | CYTB; cytb; | NULL | 378 | human |
| B4YG26 | NADH-ubiquinone oxidoreductase chain 6; EC 1.6.5.3; | ND6; | NULL | 174 | human |
| F1B5V3 | NADH-ubiquinone oxidoreductase chain 2; EC 1.6.5.3; | ND2; | NULL | 347 | human |
| E9PJA6 | Calpain-1 catalytic subunit; Fragment; | CAPN1; | NULL | 162 | human |
| G9LKI3 | NADH-ubiquinone oxidoreductase chain 2; EC 1.6.5.3; | ND2; | NULL | 347 | human |
| M0R1N1 | Zinc finger protein 415; | ZNF415; | NULL | 59 | human |
| C8YDE2 | NADH-ubiquinone oxidoreductase chain 5; EC 1.6.5.3; | ND5; | NULL | 603 | human |
| B4YGJ6 | Cytochrome b; | CYTB; | NULL | 380 | human |
| A0A024R4X0 | NADH-cytochrome b5 reductase; EC 1.6.2.2; | CYB5R3; | NULL | 291 | human |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |